Table of Contents
1 EXECUTIVE SUMMARY
- Overview
- Overview of the Bladder Cancer Therapeutics Market
2 GLOSSARY OF TERMS
3 MARKET OVERVIEW
- Introduction
- Disease Characteristics
- Epidemiology
- Market Definitions and Segmentation
4 RESEARCH METHODOLOGY AT FROST & SULLIVAN
- Research Objectives and Scope
5 INDUSTRY CHALLENGES
- Challenges for the Bladder Cancer Market
- Challenges Faced by Pharmaceutical Companies
6 TOTAL EUROPEAN MARKET FOR BLADDER CANCER THERAPEUTICS
- Overview and Defintions
- Introduction
- Market Drivers
- Market Restraints
- Current Therapeutic Options - Superficial Bladder Cancer
- Current Therapeutic Options - Invasive Bladder Cancer
- Future Therapeutic Approaches
- Current Treatment Guidelines
- Market Engineering Measurement Analysis
- Competitive Analysis
- Profiles of Key Industry Participants
- Market Share Analysis
- Pipeline Analysis
7 TOTAL FORECASTS FOR THE EUROPEAN BLADDER CANCER THERAPEUTICS MARKET
- Forecasts
- Patient Forecasts and Geographical Trends
- Market Revenue Forecasts
8 PRICING AND REIMBURSEMENT IN EUROPE
- Pricing and Reimbursement Issues
- Pricing and Reimbursement - Country Analysis
- Pricing and Reimbursement
9 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN BLADDER CANCER THERAPEUTICS MARKET
- Market Engineering Recommendations
- Strategic Recommendations
10 DATABASE OF KEY INDUSTRY PARTICIPANTS
- Key Industry Participants
- Key Participants in the Bladder Cancer Therapeutics Market
11 DECISION SUPPORT DATABASES
- Habitual Indicators
- Prevalence of Male Smokers
- Prevalence of Female Smokers
- Prevalence of Smokers
- Healthcare Expenditure
- Expenditure
- Per Capita Healthcare Expenditure
- Cancer Incidence
- Bladder Cancer Incidence in Western Europe
- Bladder Cancer Incidence in Selected European Countries
- Cancer Mortality
- Bladder Cancer Mortality in Western Europe
- Bladder Cancer Mortality in Selected European Countries
|
Related Report
|
View Cart
